1. Activation of the mitogen‐activated protein kinase ERK1/2 signaling pathway suppresses the expression of ChREBPα and β in HepG2 cells
- Author
-
Daisaku Yoshihara, Haruhiko Sakiyama, Keiichiro Suzuki, Hironobu Eguchi, Noriko Fujiwara, and Lan Li
- Subjects
0301 basic medicine ,MAPK/ERK pathway ,MAP Kinase Signaling System ,QH301-705.5 ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Staurosporine ,Humans ,oxidative stress ,Biology (General) ,Carbohydrate-responsive element-binding protein ,Transcription factor ,Research Articles ,biology ,Chemistry ,Kinase ,Basic Helix-Loop-Helix Leucine Zipper Transcription Factors ,Hep G2 Cells ,ChREBPβ ,ChREBPα ,Cell biology ,staurosporine ,ERK ,030104 developmental biology ,030220 oncology & carcinogenesis ,Mitogen-activated protein kinase ,Lipogenesis ,biology.protein ,Mitogen-Activated Protein Kinases ,Oxidative stress ,medicine.drug ,Signal Transduction ,Research Article - Abstract
The carbohydrate response element‐binding protein (ChREBP), a glucose‐responsive transcription factor that plays a critical role in the glucose‐mediated induction of genes involved in hepatic glycolysis and lipogenesis, exists as two isoforms: ChREBPα and ChREBPβ. However, the mechanism responsible for regulating the expression of both ChREBPα and β, as well as the mechanism that determines which specific isoform is more responsive to different stimuli, remains unclear. To address this issue, we compared the effects of several stimuli, including oxidative stress, on the mRNA and protein expression levels of ChREBPα and β in the hepatocyte cell line, HepG2. We found that H2O2 stimulation suppressed the expression of both mRNA and protein in HepG2 cells, but the mRNA expression level of ChREBPβ was, The carbohydrate response element binding protein (ChREBP) is a glucose‐responsive transcription factor that strongly regulates glycolysis and lipogenesis. In this study, we showed that oxidative stress, including STS and TPA treatment, suppressed the expression of both ChREBPα and β through activation of ERK signaling in HepG2 cells.
- Published
- 2021